FWG Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-710
Closed -$262K 66
2024
Q4
$262K Buy
710
+59
+9% +$24.7K 0.2% 103
2024
Q3
$339K Buy
651
+52
+9% +$27.8K 0.29% 80
2024
Q2
$325K Buy
599
+38
+7% +$20.1K 0.33% 72
2024
Q1
$291K Buy
561
+5
+0.9% +$2.49K 0.32% 77
2023
Q4
$262K Buy
+556
New +$257K 0.33% 72

Other funds holding ELV

FWG Investments's ELV Position: Q1 2025 in Review

FWG Investments sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 710 shares — an estimated $262K sold.

FWG Investments first reported a position in ELV in Q4 2023 and held it in 5 quarters. The position peaked at $339K in Q3 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • FWG Investments reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • FWG Investments sold 710 Elevance Health shares in Q1 2025, an estimated $262K.
  • FWG Investments first reported a position in Elevance Health in Q4 2023 and held it in 5 quarters.
  • FWG Investments's Elevance Health position peaked at $339K in Q3 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on FWG Investments's 13F filing for Q1 2025, filed 14 May 2025.